Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia.
about
Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia.A prospective randomised controlled trial of Nd:YAG laser photocoagulation versus liquid paraffin plus antiseptic cream in the treatment of recurrent epistaxis.Long-term efficacy of Nd:YAG laser photocoagulation vs. liquid paraffin plus antiseptic cream in the treatment of recurrent epistaxis.Long-term result of out-patient neodymium-doped yttrium aluminium garnet laser photocoagulation surgery for patients with epistaxis.Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis.Technique modifications for septodermoplasty: an illustrative case.Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.Executive summary of the 11th HHT international scientific conference.Inferior turbinate mucosal graft combined with radiofrequency for the treatment of nasal hereditary haemorrhagic telangiectasia: our experience in sixteen patients.Intranasal oestrogen cream for the prevention of epistaxis in patients with bleeding disorders.Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia.Randomized controlled trial comparing Nd:YAG laser photocoagulation and bipolar electrocautery in the management of epistaxis.Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study.Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.Twenty-four-hour and annual variation in onset of epistaxis in Osler disease.Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia
P2860
Q33212390-9F2E0DCC-DE0C-47AB-8EB3-F3B26EC1F839Q33244952-C6900373-5774-4E31-AD33-7650BA9702C8Q34294167-26019C29-F8DA-48FA-BF03-E1603AC779B7Q35543963-0EDC1233-F0E3-4D91-A193-DEA8A747E661Q35850821-20837F49-2CAC-42B7-8BA1-FBD66ED65038Q36114037-4397CD61-E955-4970-884E-BFE9F42D47B3Q36416717-5D746723-2340-4034-A6AA-178326A99EDAQ36480144-4CAEA9BE-EE9C-4ED1-9167-0C937232C800Q37116795-87C8BD03-5E84-4E7F-8D01-B3FF4B29B527Q38008300-C80E28FB-2EB3-437B-8BF6-FAB3F32814B8Q43162320-FA32276B-AFB6-4096-80DD-EF465FA8AFB1Q44800182-49D9D596-C6CA-4389-98C5-4C03BA2ABE0DQ44889172-2D60867E-9067-4BF2-B639-4059CD549F78Q45862005-5C37B647-A36B-4BE3-97BA-86126B498D17Q46152895-8C07A2E4-DD2C-4E91-A581-840EDE6667D3Q46283167-CDE29328-C824-446F-8A21-FB52A976B187Q47322514-B30D75EA-8A21-4E5B-A9CB-3EA9691B1B45Q48191418-097B8226-8B29-430D-8265-F9D8343AFD04Q48372227-AC35C1D3-D612-4548-A94E-ED56F26E2A2DQ50803308-AE5FF9C1-2127-40C5-831F-701FE5A29D20Q58125263-5EF738AC-0069-4A7A-89CA-E819E70E7007
P2860
Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Topical estrogens combined wit ...... ry hemorrhagic telangiectasia.
@ast
Topical estrogens combined wit ...... ry hemorrhagic telangiectasia.
@en
type
label
Topical estrogens combined wit ...... ry hemorrhagic telangiectasia.
@ast
Topical estrogens combined wit ...... ry hemorrhagic telangiectasia.
@en
prefLabel
Topical estrogens combined wit ...... ry hemorrhagic telangiectasia.
@ast
Topical estrogens combined wit ...... ry hemorrhagic telangiectasia.
@en
P2093
P2860
P1476
Topical estrogens combined wit ...... ry hemorrhagic telangiectasia.
@en
P2093
Frank Riedel
Haneen Sadick
Karl Gotte
Karl Hörmann
Wolfgang Bergler
P2860
P304
P356
10.1177/000348940211100306
P433
P577
2002-03-01T00:00:00Z